Fetal Distribution of 5α-Reductase 1 and 5α-Reductase 2, and Their Input on Human Prostate Development

Autor: Lunacek, A., Schwentner, C., Oswald, J., Fritsch, H., Sergi, C., Thomas, L.N., Rittmaster, R.S., Klocker, H., Neuwirt, H., Bartsch, G., Radmayr, C. ^†

Publikováno v: In The Journal of Urology 2007 178(2):716-721

EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER

Autor: ANDRIOLE, G.L., HUMPHREY, P., RAY, P., GLEAVE, M.E., TRACHTENBERG, J., THOMAS, L.N., LAZIER, C.B., RITTMASTER, R.S.

Publikováno v: In The Journal of Urology 2004 172(3):915-919

Effect of dutasteride on the risk of prostate cancer

Autor: Andriole, G.L., Bostwick, D.G., Brawley, O.W., Gomella, L.G., Marberger, M., Montorsi, F., Pettaway, C.A., Tammela, T.L.J., Teloken, C., Tindall, D.J., Somerville, M.C., Wilson, T.H., Fowler, I.L., Rittmaster, R.S., Mulders, P.F.A., Schrier, B.P.

Publikováno v: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2010, 362 (13), pp.1192-1202. 〈10.1056/NEJMoa0908127〉
The New England Journal of Medicine, 362, 13, pp. 1192-202
The New England Journal of Medicine, 362, 1192-202
New England Journal of Medicine, Massachusetts Medical Society, 2010, 362 (13), pp.1192-1202. ⟨10.1056/NEJMoa0908127⟩

Background: We conducted a study to determine whether dutasteride reduces the risk of incident prostate cancer, as detected on biopsy, among men who are at increased risk for the disease. Methods: In this 4-year, multicenter, randomized, double-blind

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6fa3ab27f971d1b316531701f9a115c
https://hal.archives-ouvertes.fr/hal-00493661

983 UTILITY OF COMBINING FINAL PSA AND PSA DYNAMICS (CHANGE FROM MONTH 6 TO FINAL PSA) FOR PROSTATE CANCER AND HIGH GRADE CANCER DIAGNOSIS IN THE REDUCE STUDY

Autor: Montorsi, F., Freedland, S.J., Tammela, T.L.J., Tindall, D.J., Teloken, C., Somerville, M.C., Wilson, T.H., Rittmaster, R.S.

Publikováno v: In European Urology Supplements April 2010 9(2):308-308

Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia in the Combination of Avodart and Tamsulosin (CombAT) trial

Autor: Roehrborn, C.G., Tubaro, A., Barkin, J., Wilson, T.H., Gagnier, R.P., Castro, R., Rittmaster, R.S.

Publikováno v: In Journal of Men's Health 2009 6(3):268-268